|

MGD024 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • MacroGenics1

Indications

  • Mastocytosis, Aggressive Systemic1
  • Leukemia, Hairy Cell1
  • Leukemia, Acute Myeloid1
  • Classical Hodgkin Lymphoma1
  • Leukemia, B-cell1

Denver, Colorado1 trial

A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies

Colorado Blood Cancer Network

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.